193 related articles for article (PubMed ID: 21220489)
1. Targeting tyrosine phosphorylation of PCNA inhibits prostate cancer growth.
Zhao H; Lo YH; Ma L; Waltz SE; Gray JK; Hung MC; Wang SC
Mol Cancer Ther; 2011 Jan; 10(1):29-36. PubMed ID: 21220489
[TBL] [Abstract][Full Text] [Related]
2. Targeting the EGFR/PCNA signaling suppresses tumor growth of triple-negative breast cancer cells with cell-penetrating PCNA peptides.
Yu YL; Chou RH; Liang JH; Chang WJ; Su KJ; Tseng YJ; Huang WC; Wang SC; Hung MC
PLoS One; 2013; 8(4):e61362. PubMed ID: 23593472
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of a novel small molecule targeting PCNA chromatin association in prostate cancer.
Dillehay KL; Lu S; Dong Z
Mol Cancer Ther; 2014 Dec; 13(12):2817-26. PubMed ID: 25253786
[TBL] [Abstract][Full Text] [Related]
4. The Ron receptor tyrosine kinase activates c-Abl to promote cell proliferation through tyrosine phosphorylation of PCNA in breast cancer.
Zhao H; Chen MS; Lo YH; Waltz SE; Wang J; Ho PC; Vasiliauskas J; Plattner R; Wang YL; Wang SC
Oncogene; 2014 Mar; 33(11):1429-37. PubMed ID: 23542172
[TBL] [Abstract][Full Text] [Related]
5. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
Igawa T; Lin FF; Rao P; Lin MF
Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
[TBL] [Abstract][Full Text] [Related]
6. Interaction of proliferation cell nuclear antigen (PCNA) with c-Abl in cell proliferation and response to DNA damages in breast cancer.
Zhao H; Ho PC; Lo YH; Espejo A; Bedford MT; Hung MC; Wang SC
PLoS One; 2012; 7(1):e29416. PubMed ID: 22238610
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of PCNA by EGFR inhibits mismatch repair and promotes misincorporation during DNA synthesis.
Ortega J; Li JY; Lee S; Tong D; Gu L; Li GM
Proc Natl Acad Sci U S A; 2015 May; 112(18):5667-72. PubMed ID: 25825764
[TBL] [Abstract][Full Text] [Related]
8. The Functions of PCNA in Tumor Stemness and Invasion.
Wang YL; Wu WR; Lin PL; Shen YC; Lin YZ; Li HW; Hsu KW; Wang SC
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628489
[TBL] [Abstract][Full Text] [Related]
9. Fangchinoline induced G1/S arrest by modulating expression of p27, PCNA, and cyclin D in human prostate carcinoma cancer PC3 cells and tumor xenograft.
Wang CD; Huang JG; Gao X; Li Y; Zhou SY; Yan X; Zou A; Chang JL; Wang YS; Yang GX; He GY
Biosci Biotechnol Biochem; 2010; 74(3):488-93. PubMed ID: 20208355
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation at tyrosine 114 of Proliferating Cell Nuclear Antigen (PCNA) is required for adipogenesis in response to high fat diet.
Lo YH; Ho PC; Chen MS; Hugo E; Ben-Jonathan N; Wang SC
Biochem Biophys Res Commun; 2013 Jan; 430(1):43-8. PubMed ID: 23201573
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of Id1 by small interfering RNA in prostate cancer PC3 cells in vivo and in vitro.
Ling YX; Tao J; Fang SF; Hui Z; Fang QR
Eur J Cancer Prev; 2011 Jan; 20(1):9-17. PubMed ID: 20881502
[TBL] [Abstract][Full Text] [Related]
12. Phenoxodiol inhibits growth of metastatic prostate cancer cells.
Aguero MF; Venero M; Brown DM; Smulson ME; Espinoza LA
Prostate; 2010 Aug; 70(11):1211-21. PubMed ID: 20564423
[TBL] [Abstract][Full Text] [Related]
13. MUC1 oncoprotein is a druggable target in human prostate cancer cells.
Joshi MD; Ahmad R; Yin L; Raina D; Rajabi H; Bubley G; Kharbanda S; Kufe D
Mol Cancer Ther; 2009 Nov; 8(11):3056-65. PubMed ID: 19887552
[TBL] [Abstract][Full Text] [Related]
14. Nanomicellar TGX221 blocks xenograft tumor growth of prostate cancer in nude mice.
Chen R; Zhao Y; Huang Y; Yang Q; Zeng X; Jiang W; Liu J; Thrasher JB; Forrest ML; Li B
Prostate; 2015 May; 75(6):593-602. PubMed ID: 25620467
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of proliferation of prostate cancer cell line, PC-3, in vitro and in vivo using (-)-gossypol.
Zhang XQ; Huang XF; Mu SJ; An QX; Xia AJ; Chen R; Wu DC
Asian J Androl; 2010 May; 12(3):390-9. PubMed ID: 20081872
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor protects proliferating cell nuclear antigen from cullin 4A protein-mediated proteolysis.
Lo YH; Ho PC; Wang SC
J Biol Chem; 2012 Aug; 287(32):27148-57. PubMed ID: 22692198
[TBL] [Abstract][Full Text] [Related]
17. A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: involvement of nuclear factor-kappaB signaling.
Hafeez BB; Siddiqui IA; Asim M; Malik A; Afaq F; Adhami VM; Saleem M; Din M; Mukhtar H
Cancer Res; 2008 Oct; 68(20):8564-72. PubMed ID: 18922932
[TBL] [Abstract][Full Text] [Related]
18. Additive effects of a small molecular PCNA inhibitor PCNA-I1S and DNA damaging agents on growth inhibition and DNA damage in prostate and lung cancer cells.
Lu S; Dong Z
PLoS One; 2019; 14(10):e0223894. PubMed ID: 31600334
[TBL] [Abstract][Full Text] [Related]
19. p53 mutant-type in human prostate cancer cells determines the sensitivity to phenethyl isothiocyanate induced growth inhibition.
Aggarwal M; Saxena R; Asif N; Sinclair E; Tan J; Cruz I; Berry D; Kallakury B; Pham Q; Wang TTY; Chung FL
J Exp Clin Cancer Res; 2019 Jul; 38(1):307. PubMed ID: 31307507
[TBL] [Abstract][Full Text] [Related]
20. miR-363-3p inhibits tumor growth by targeting PCNA in lung adenocarcinoma.
Wang Y; Chen T; Huang H; Jiang Y; Yang L; Lin Z; He H; Liu T; Wu B; Chen J; Kamp DW; Liu G
Oncotarget; 2017 Mar; 8(12):20133-20144. PubMed ID: 28423618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
